npj Parkinson's Disease (Mar 2024)

Matters arising: In vivo effects of the alpha-synuclein misfolding inhibitor minzasolmin supports clinical development in Parkinson’s disease

Michel Alexander Steiner

Affiliations

Michel Alexander Steiner: Idorsia Pharmaceuticals Ltd, CNS Pharmacology

DOI: https://doi.org/10.1038/s41531-024-00657-7
Journal volume & issue: Vol. 10, no. 1
pp. 1 – 2

Abstract

No abstracts available.

Published in npj Parkinson's Disease

ISSN: 2373-8057 (Online)
Publisher: Nature Portfolio
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system
Website: https://www.nature.com/npjparkd/

About the journal